Immunome IMNM
NASDAQ IMNM
$21.94 +0.06 (+0.25%)
As of: Sep 30, 2026 · 9:50 AM EDT

Immunome (IMNM) FCF Margin (2023 - 2025)

Updated

Immunome's FCF Margin was -2890.13% in FY2025, down 1585.33 percentage points from -1304.80% in FY2024.

Analysis

Immunome (IMNM) FCF Margin (2023 - 2025) Analysis & Trends

  • Per Business Quant data, FCF Margin in earlier years was -1304.80% in FY2024 (-1244.88 pp) and -59.92% in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 Immunome 2.46 Bn 429.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -1,252.95%
Mar 31, 2025 -1,938.48%
Dec 31, 2024 -1,577.28%
Sep 30, 2024 -1,227.01%
Jun 30, 2024 -1,088.87%
Mar 31, 2024 -1,295.82%
Dec 31, 2023 -465.45%
Sep 30, 2023 -242.64%
Jun 30, 2023 -140.93%
Mar 31, 2023 1,018.06%
API Access

Immunome FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=IMNM&period=max&api_key=YOUR_API_KEY